Roberfroid M B
Arch Toxicol. 1980 Nov;46(1-2):181-93. doi: 10.1007/BF00361256.
The metabolic pathways of chemical compounds of pharmaceutical interest are reviewed in relation to the role of activation and detoxification in the process of mutagenicity. The properties and subcellular localization of the enzymes involved are given together with the main reactions they catalyze. The role of metabolism in mutagenicity testing in vitro is discussed with special emphasis on the choice of the enzymatic system. Parameters such as species, strain, sex, diet, and induction are considered. The effect of various enzymatic effectors added in vitro is also discussed. It is concluded that the metabolism of drugs is very complex, involving both activation and detoxification processes catalyzed by a large variety of enzymes. Production of mutations in vitro in prokaryotic or eukaryotic cells is the results of a balance between all those pathways. Metabolic activation thus merits special attention.
结合激活和解毒在致突变过程中的作用,对具有药学意义的化合物的代谢途径进行了综述。给出了所涉及酶的性质和亚细胞定位以及它们催化的主要反应。讨论了代谢在体外致突变性测试中的作用,特别强调了酶系统的选择。考虑了物种、品系、性别、饮食和诱导等参数。还讨论了体外添加的各种酶效应物的作用。得出的结论是,药物代谢非常复杂,涉及由多种酶催化的激活和解毒过程。原核或真核细胞体外突变的产生是所有这些途径之间平衡的结果。因此,代谢激活值得特别关注。